Brussels, 02/03/2001 (Agence Europe) - The European Commission gave the go ahead to the acquisition by the American Abbott group (health care) of the world-wide pharmaceutical activities of the German BASF AG. The operation leads to overlaps in Belgium, Spain and in Austria for some medicines and therapeutic products, but the combined market share remains weak. At the level of the products being developed, the Commission felt that, in the cases where there are overlaps, the products were...